There is no single piece of clinical trial software. What people call a trial platform is really a stack of eight to ten separate systems, each solving a different problem, sold by different vendors, and bought by different people inside the same organization. The data manager picks the EDC. The regulatory lead picks the eTMF. The site coordinator lives in a CTMS that nobody at the sponsor has ever logged into.
Most roundups ignore this and hand you ten products that do overlapping things, which is useless when you are trying to work out what you are actually missing. So this guide is organized by category instead. Eleven categories, one recommended tool in each, picked because it is the best at that one job.
Every vendor link below was checked before publication, and where a product has been acquired or renamed we say so in its section. This industry consolidates fast enough that a roundup written from other roundups will send you to at least one company that no longer exists.
How to evaluate any category
Before you compare products inside a category, work out whether you need that category at all. A single site running three studies a year does not need an eTMF or a safety database. A sponsor running forty trials needs both, plus a randomization system it can trust at three in the morning. Buying software for a scale you have not reached is the most common and most expensive mistake in this market.
Once you know the category is real for you, these five questions separate the vendors.
How long does a study take to build? The gap here is enormous. Some platforms let a study manager configure forms without writing code and go live in weeks. Enterprise systems often need a specialist and a longer validation cycle. Ask for the number, for a study of your complexity, not a best case.
Who actually uses it every day? Coordinators and site staff, not sponsors, spend the most hours inside these systems. If site staff already know a platform, training cost drops sharply and data quality tends to follow. This single factor explains most of why incumbents keep winning.
What happens during a protocol amendment? Amendments are normal. What matters is whether deploying one takes hours or months, and whether sites lose access while it happens.
Does it genuinely share a database with its neighbors? Nearly every vendor markets a unified platform, but the meaning varies. Modules on one system remove reconciliation work. Separate products stitched together with integrations do not, whatever the sales deck says.
Who owns it now? This industry consolidates constantly. The tool you shortlist may have been acquired twice since the review you read. Check the vendor’s own site, not a comparison article, before you take a demo.
The eleven categories at a glance
| Category | Our pick | Who buys it |
|---|---|---|
| Electronic data capture | Medidata Rave | Sponsors and CROs |
| eClinical platform for small teams | Castor | Biotech, device, academia |
| Trial master file | Veeva Vault eTMF | Regulatory and clinical operations |
| Randomization and trial supply | Suvoda | Sponsors and supply chain |
| Patient outcome data | Signant Health | Sponsors and CROs |
| Drug safety and pharmacovigilance | Oracle Safety One Argus | Safety and pharmacovigilance teams |
| Site trial management | Clinical Conductor | Sites, hospitals, site networks |
| Site eRegulatory and eISF | Florence eBinders | Site regulatory staff |
| Participant payments | Greenphire | Sponsors and sites |
| Recruitment and enrollment | EnrollNow | Academic and translational teams |
| Time, cost, and project operations | actiTIME | CRO and site operations, finance |
Best clinical trial software of 2026 by category
1. Electronic data capture: Medidata Rave
Key features:
- Protocol amendments without downtime
- EHR to EDC population through Rave Companion
- Rave Lite for Phase I, Phase IV, and device studies
- Connected eCOA, eConsent, RTSM, and imaging modules
The EDC is where participant data lives: lab values, adverse events, visit outcomes, everything a regulator will eventually ask to see. It is the first system most organizations buy and the hardest to replace once sites learn it.
Rave is the closest thing the industry has to a default. Medidata cites the 2025 ISR Benchmarking Report, which surveys sponsors independently, as rating Rave the most preferred EDC. That reputation has a practical payoff, because a large share of experienced coordinators have already worked in Rave and need almost no training. The capability worth singling out is mid study change handling: Medidata states amendments deploy with no downtime, reaching thousands of patients in hours rather than months. For adaptive designs, that alone can justify the platform.
Best for: sponsors and CROs whose sites already know the system. Alternatives: Veeva Vault CDMS, Oracle Clinical One, Medrio.
2. eClinical platform for small teams: Castor
Key features:
- Study build without writing code
- EDC, CDMS, eCOA, ePRO, and eConsent on one system
- Castor Catalyst for AI clinical data extraction
- Registry, post market, and real world evidence studies
Enterprise EDCs assume you have a clinical programming function. Most biotech, device, and academic teams do not, and they need one system that covers capture, consent, and outcomes without a six month implementation.
Castor dropped the EDC from its name as the product outgrew the category. By its own published figures it has supported more than 18,000 studies across over 160 countries, with low complexity studies launching in three to four weeks. The reason it belongs here in 2026 is Castor Catalyst, an AI layer that reads source documents such as scans, EHR exports, and physician notes, then proposes structured values for the case report form. Every value carries a confidence score, sits beside its source, and needs a human reviewer to accept or reject it before it enters the record. Castor reports that across twelve comparative studies in 2023 and 2024 this cut per chart review from roughly 39 minutes to about 6, at an error rate under 0.7 percent against 6.6 percent for manual review. Those are vendor published numbers and deserve the scrutiny you would give any vendor benchmark, but the human in the loop design is the right architecture and the claimed gains are large enough to be worth testing.
Best for: biotech, medical device, and academic teams that want modern tooling without an enterprise implementation. Alternatives: Medrio, OpenClinica, Anju eClinical Suite.
3. Trial master file: Veeva Vault eTMF
Key features:
- Expected Document Lists for automated completeness checks
- Risk based quality control workflows
- Version control and real time co authoring
- TMF exchange between sponsors and partners
The trial master file is the evidence that your trial was run properly. When an inspector arrives, the TMF is what they read. Running it on shared drives is how organizations end up spending months reconstructing documents before an inspection.
Veeva Vault eTMF is the category leader for enterprise sponsors and CROs, with more than 500 customers. What it changes is the rhythm of TMF work, which stops being a filing exercise and becomes a continuous one. Expected Document Lists flag what is missing while the trial is still running, and risk based quality control sends reviewers to the documents most likely to matter instead of checking everything equally. If your organization already runs Veeva for regulatory documents or study startup, the case is close to automatic.
Best for: sponsors and CROs that need continuous inspection readiness. Alternatives: MasterControl, Viedoc.
4. Randomization and trial supply: Suvoda
Key features:
- Interactive response technology for randomization
- Drug supply forecasting and dispensing
- Deployment in as little as two weeks
- Built for oncology, central nervous system, and rare disease trials
Randomization and trial supply management, known as RTSM or IRT, decides which arm a patient enters and makes sure the right drug is at the right site when they arrive. It is unglamorous and it is the system most likely to stop a trial dead when it fails.
Suvoda specializes in exactly the trials where this goes wrong: complex oncology, central nervous system, and rare disease protocols with intricate randomization schemes and fragile supply chains. The company reports support for more than 6,000 trials across 115 countries, RTSM deployment in as little as two weeks, and that 34 percent of trials using its technology went on to FDA approval. Treat that last figure as a fact about who hires Suvoda rather than proof of what Suvoda causes, but the speed of deployment is a genuine differentiator in a category where twelve week builds are normal.
Best for: sponsors running complex randomization or constrained drug supply. Alternatives: 4G Clinical Prancer, Oracle Clinical One RTSM, Medidata RTSM.
5. Patient outcome data: Signant Health
Key features:
- eCOA covering patient, clinician, and observer reported outcomes
- Bring your own device and provisioned device options
- Data quality controls for endpoint reliability
- More than 30 years of clinical trial experience
Electronic clinical outcome assessment, or eCOA, captures what the patient reports: symptoms, quality of life, pain scores, the endpoints that increasingly decide whether a drug is approved. Getting it wrong quietly corrupts your primary endpoint, which is not a thing you discover early.
Signant Health is a specialist rather than a platform vendor with an eCOA module bolted on, and in this category the specialists still lead. The interesting decision it forces is modality: whether participants use their own phones or devices you provision. Signant supports both, and its guidance on choosing between them is more candid than most vendor material, which tells you something about how contested that choice actually is in practice.
Best for: sponsors where patient reported outcomes carry a primary or key secondary endpoint. Alternatives: Clario, YPrime, Medidata eCOA, Castor.
6. Drug safety and pharmacovigilance: Oracle Safety One Argus
Key features:
- Global adverse event case processing
- Automated case intake and E2B regulatory reporting
- Signal detection through Oracle Empirica
- Post marketing surveillance
A safety database records adverse events, processes them into regulatory cases, and files them with health authorities inside legally binding deadlines. Miss those deadlines and the consequences are regulatory, not commercial.
Argus, now sold as Oracle Life Sciences Safety One Argus, is the most widely deployed pharmacovigilance platform in the industry, and its ubiquity is self reinforcing: the people you hire already know it. It handles high volume case processing, automated intake, and expedited reporting, while Oracle Empirica covers signal detection across data sources. This is a category where the boring, established choice is usually the correct one, because the cost of a failure here is regulatory action, not lost productivity.
Best for: any organization with post marketing products or regulatory reporting obligations. Alternatives: ArisGlobal LifeSphere, Veeva Vault Safety.
7. Site trial management: Clinical Conductor
Key features:
- Visit scheduling and participant engagement
- Financial analytics and invoicing against procedures
- CCText for participant messaging
- CCPay for participant payments
A CTMS runs the operational business of a research site: who is enrolled, when visits happen, what each procedure earns, and whether the site is being paid. It is the system sponsors most often forget exists, and the one site directors care about most.
Clinical Conductor is built for sites rather than sponsors, and the financial layer is what site directors buy it for. Budget tracking, invoicing against completed procedures, and cross study reporting give a site network real visibility into which trials are worth running at all. Advarra acquired the original maker, Bio-Optronics, in 2021, and the product now sits inside Advarra’s wider site technology portfolio, which matters if you also use Advarra for IRB services.
Best for: hospitals, health systems, cancer centers, and site networks running many studies at once. Alternatives: RealTime-CTMS, Anju CTMS Master.
8. Site eRegulatory and eISF: Florence eBinders
Key features:
- Electronic investigator site file and participant binders
- Remote monitor access to source documents
- Audit trails and electronic signatures
- Electronic logs replacing paper
The investigator site file is the site’s own regulatory record, the local counterpart to the sponsor’s TMF. Historically it was a wall of binders, and monitors flew across the country to read them.
Florence eBinders digitizes that file, and its market position is unusually clear: Florence describes it as the most adopted electronic investigator site file in clinical research, in use at more than 30,000 sites. The feature that changed site economics is remote monitor access. A monitor reviews documents without traveling, which removes cost from the sponsor and interruption from the site. If you run a site still working from paper binders, this category will return more time per dollar than almost anything else on this list.
Best for: research sites moving off paper regulatory binders. Alternatives: Complion, Veeva SiteVault.
9. Participant payments: Greenphire
Key features:
- Real time payments in local currency
- Debit card, virtual card, and bank deposit options
- Travel and expense reimbursement
- Reporting for sponsors and CROs
Participants incur real costs to join a trial: travel, parking, lost wages, childcare. Paying them slowly, or making a coordinator process reimbursements by hand, is a retention problem disguised as an administrative one.
Greenphire is the established name here, and its ClinCard is familiar enough that many academic medical centers name it directly in their participant payment procedures. Payments reach participants in local currency through their preferred method, and the site workload of executing them largely disappears. Note that Greenphire merged with Suvoda in 2025, so this category and randomization now sit under one owner. That is convenient if you want both and worth knowing if you would rather not concentrate two systems with one vendor.
Best for: sponsors and sites where participant burden threatens retention. Alternatives: Advarra CCPay, Mural Health.
10. Recruitment and enrollment: EnrollNow
Key features:
- Participant prescreening workflows
- Visit scheduling and engagement
- Study management for research teams
- Secure handling of participant data
Recruitment is the reason most trials run late. No amount of elegant data capture helps a study that cannot fill its arms, and enrollment work rarely fits neatly into either the EDC or the CTMS.
EnrollNow is the product formerly known as Ripple Science, rebranded in 2025. It does one thing and leaves the rest alone: moving people through prescreening, enrollment, scheduling, and ongoing engagement. Built by researchers for researchers, it is most at home in clinical, translational, and social science studies. If your data systems are settled and your bottleneck is the pipeline of participants, not the data coming out of them, a focused tool here will do more for the study than another platform module.
Best for: academic and translational research teams where enrollment is the constraint. Alternatives: OpenClinica Study Hub, the recruitment tools inside Clinical Conductor.
11. Time, cost, and project operations: actiTIME
Key features:
- Clinical trial timesheets tracked by customer, project, and task
- Cost of Work, Billing Summary, and Profit/Loss reports per study
- Clinical trial budget tracking with overrun alerts
- PDF invoices generated from billable time
- Self hosted option for data residency
Every category above manages the trial. None of them tells you what the trial costs to run. Which hours went into which study, what those hours cost, and whether the contract covers them sits outside the EDC and outside most CTMS reporting. This is where contract research organizations and research sites lose margin without noticing, and it is a category, not an afterthought.
The problem is measurable. A 2024 study in the Journal of Clinical and Translational Research found that coordinator workload differs significantly between federally funded and industry sponsored protocols, and that trial complexity scores predict coordinator hours well enough to plan capacity from them. In other words, studies do not cost what the budget template assumed they would, and the only way to find out is to record the hours against the study.
actiTIME is time tracking software for clinical trials that connects hours to financial outcomes. Be clear about what it is: a commercial and operational tool, not a replacement for your EDC or CTMS, and not a regulated system of record. It answers the money question the clinical stack leaves open. Research staff fill in a clinical trial timesheet week by week, or log exact start and stop intervals on a calendar view, with a mobile app for capturing time between visits and a Chrome extension with an automatic timer for desk work.
Why actiTIME is the right choice for clinical trial organizations
-
It turns hours into money.
Most time trackers stop at a total. actiTIME applies a cost of work rate per employee and a billing rate per type of work, so the Cost of Work report shows staff expense per study, the Billing Summary shows what is billable, and the Profit/Loss report compares the two by customer, project, or task. That turns a timesheet into clinical trial financial management, and it is the one feature that separates it from the free timers most sites start with.
-
Its structure already matches how a study is organized.
Work is arranged as customer, then project, then task, and all three labels are renameable in settings. Sites map them to sponsor, protocol, and visit or procedure. Nothing has to be forced into a shape built for software teams, which is the usual failure mode when research organizations adopt a generic project tool.
-
Budgets mirror how trial budgets are actually negotiated.
Cost, billing, and time budgets can be set at the customer, project, or task level, each with a progress bar that turns red on overrun. Because budgets attach at task level, the unreimbursed work that steadily erodes site margin, screen failures and monitoring visits above all, stops being a hunch and starts being a number.
-
Closed periods stay closed.
Managers can require timesheet approval and then lock time entries once a period closes, so figures cannot shift after an invoice has gone out. Anyone who has reconciled clinical research billing against a moving timesheet will understand why this matters.
-
It runs where your data has to live.
Academic centers and organizations with data residency obligations can install actiTIME on their own infrastructure instead of a vendor cloud, for a one time fee. Few tools that also handle costing and invoicing will let you do that.
The effort reporting angle matters for anyone holding federal awards. Under 2 CFR 200.430, salaries charged to a federal award must be supported by records that accurately reflect the work performed. actiTIME produces those underlying time records and the reports that summarize them by project and person. Formal effort certification still belongs in your research administration system, and actiTIME should not be treated as a validated repository for regulated trial data, but the hours it captures are the raw material those processes run on.
Unlike everything else on this list, the pricing is public. The cloud version starts at $5 per user each month, a permanent free version covers teams of up to three users, and organizations with data residency requirements can run a self hosted installation on their own infrastructure for a one time payment of $120 per user. Every version includes human support and free onboarding, so a site can pilot it on one protocol before committing.
Best for: CRO and site operations and finance teams that need to know study cost, billable hours, and profitability per protocol. Alternatives: general purpose time trackers and clinical trial budget software, though the former stop at recording hours and the latter rarely capture staff time at all.
actiTIME enables us to balance workload better
I found in actiTIME all the requirements I was looking for. We are getting a lot of benefits – the tool enables us to better balance workload, have a constant view of what people are doing. I really recommend it, I evaluated a lot of tools, also had an in-house development before which demanded a lot of maintenance, and actiTIME solved all problems with no hassle.
If you run trials for clients, our guide on how to use actiTIME for contract research organizations walks through the setup, and we have written separately about the challenges contract research organizations face.
How to choose
Work out which categories apply to you before you compare any products. Sites need a CTMS, an eRegulatory system, and cost visibility. Sponsors need data capture, a trial master file, randomization, safety, and outcomes. Almost nobody needs all eleven, and the organizations that buy all eleven early are usually the ones that regret it.
Then ask each vendor the three questions that separate them: how long a study of our complexity takes to build, what happens to sites during a protocol amendment, and which of your modules actually share one database. The answers vary far more than the marketing pages suggest.
Frequently asked questions
What is clinical trial software?
Clinical trial software is not one product but a category of systems used to design, run, and report a clinical study. The main categories are electronic data capture for participant data, a trial master file for regulatory documents, a clinical trial management system for site operations, randomization and supply management, patient outcome collection, a safety database, and supporting tools for consent, recruitment, payments, and cost tracking.
What is the difference between an EDC and a CTMS?
An EDC captures the clinical data collected from participants, such as lab values, adverse events, and visit outcomes. A CTMS manages the operational business of running the study, covering recruitment, visit scheduling, staff tasks, budgets, and site payments. They answer different questions, and most organizations running trials at any scale need both.
How many of these categories do we actually need?
It depends entirely on your role. A single research site typically needs a CTMS, an eRegulatory system, and a way to track time and cost, while using whatever EDC each sponsor mandates. A sponsor needs the EDC, eTMF, RTSM, safety database, and eCOA, and generally never touches a site CTMS. Buying categories you have not grown into is the most common mistake in this market.
How much does clinical trial software cost?
None of the clinical vendors covered here publish list pricing. Quotes are built around the number of studies, sites, and users, plus which modules you enable, and enterprise platforms typically carry implementation and validation costs on top of licensing. Expect a scoping conversation with each shortlisted vendor. You will not find published prices to compare. actiTIME is the exception, with pricing published openly.
Where does time tracking fit into a clinical trial stack?
Trial platforms record what happened to patients. They rarely record what the work cost. A time tracking tool sits alongside the EDC and CTMS, attributing staff hours to specific studies and converting them into cost, billable amounts, and margin. For contract research organizations billing sponsors, and for sites deciding which trials to accept, that information determines profitability.
Getting started
Whichever platforms run the trial, the hours behind them still need accounting for. Learn how to set up time tracking in five steps, or start with the permanent free version for up to 3 users or run a full-featured 30-day trial at no cost.
